Hôpital Necker Assistance Publique- Hôpitaux de Paris
Paris, 75015, France
NCT Number: NCT02184650
The main goal of this study is to determine, in preterm infants born with a GA < 32 weeks, the association between:
* the quantity of mother's milk and duration and breastfeeding * the intake of polyunsaturated fatty acids and iron during hospitalizations
Looking for future studies?
Notify Me3 year–3 year
All sexes
Observational
Paris, 75015, France
The main hypothesis of this study is that the intake of lipid during hospitalization in neonatology department is associated with neurological development of preterm infants born with a GA < 32 weeks. The other hypotheses are that iron intake and the duration of breastfeeding are also associated with the development of preterm infants.
In the previous study EPINUTRI (NCT01486173), the development of infants was evaluated until the age of 1 year. EPINUTRI_3 is the follow-up of EPINUTRI until the age of 3 years.
The aim of EPINUTRI_3 study is to determine the association between lipid intake during hospitalization in neonatology department of preterm infants born with a GA < 32 weeks.
The secondary objective is :
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At 3 years of age: ASQ (filled in by parents)
Time frame: At 3 years of age
Age and Stages Questionnaire
Assistance Publique - Hôpitaux de Paris
Other
Early Nutrition and Neurological Development of Very Preterm Infants
Acronym: EPINUTRI_3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03114644
Female Urogenital Diseases and Pregnancy Complications, Mother-Baby Synchrony
Amiens, Picardie, France
View Trial DetailsNCT03093337
Cognition Disorders, Cognitive Dysfunction
Albi, Midi-Pyrénées, France
View Trial DetailsNCT06959290
Agnosia, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03586102
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Birmingham, Alabama, United States
View Trial Details